Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Core / Intermediate Bond · Columbia Threadneedle

Columbia Flexible Capital Income Fund Columbia Flexible Capital Income Fund Institutional 2 Class (CFXRX)

Ticker CFXRX · Since 2012-11-08 · · Holdings as of May 31, 2026

Expense ratio
0.85%$85/yr per $10k
5-yr return
+7.4%annualized
1-yr return
+12.8%as of Dec 2025
Net assets
$1.4Ball share classes
Holdings
170

Bottom line

Is CFXRX a good fund? The bottom line

CFXRX is a share class of Columbia Flexible Capital Income Fund, a managed core / intermediate bond mutual fund from Columbia Threadneedle.

It charges 0.85% — about $85 a year on every $10,000 invested, more expensive than 61% of core / intermediate bond funds we track.

It returned +12.8% over one year, +7.4% a year over five years, +9.5% a year over ten (as of Dec 31, 2025, per its prospectus).

With $1.4 billion in net assets and 170 holdings, its largest position is Hp Enterprise Co (1.5%) and the top 10 make up 12.3% of the portfolio.

What stands out

  • 5-year return beat 89% of category peers
  • No front-end sales load

Updated Nov 19, 2026

What CFXRX invests in

Columbia Flexible Capital Income Fund (the Fund) seeks to provide shareholders current income, with long-term capital appreciation.

In pursuing its investment objective, the Fund invests broadly in debt, equity and/or hybrid (convertible) securities. The Fund allocates its investments from one asset class to another based on analysis by the portfolio managers of the opportunities for the Fund to achieve its objective in a given market. The Funds investments in debt securities may include investment grade and non-investment grade bonds, bank loans and U.S. Government securities. The Fund may invest up to 100% of its assets in debt instruments that, at the time of purchase, are rated below investment grade or are unrated but determined to be of comparable quality (commonly referred to as high-yield investments or junk bonds). The Fund may invest in privately placed and other securities or instruments that are purchased and sold pursuant to Rule 144A or other exemptions under the Securities Act of 1933, as amended…

From the fund's prospectus (filed Sep 24, 2026).

CFXRX performance

Average annual total returns
1 yr5 yr10 yr
CFXRX+12.8%+7.4%+9.5%
Core / Intermediate Bond median+7.2%+1.4%+3.0%

Source: Fund prospectus, as of Dec 31, 2025

Full CFXRX performance history →

What CFXRX costs

On a $10,000 investment, CFXRX's 0.85% expense ratio costs about $85 a year. The prospectus estimates $1,049 in total costs over 10 years (assuming 5% annual returns). The median core / intermediate bond fund charges 0.71%.

See the full CFXRX fee table →

CFXRX top 10 holdings

#Holding% of fund
1Hp Enterprise Co1.52%
2Texas Instruments Inc1.47%
3Cisco Systems Inc1.40%
4Oracle Corp1.36%
5Microchip Technology Inc1.19%
6CVS Health Corp1.18%
7Morgan Stanley1.15%
8Boeing Co/the1.07%
9Starz Capital Holdings0.97%
10Columbia Short Term Cash Fund0.97%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 12.3% of the fund. See all top 25 holdings and asset mix →

Alternatives to CFXRX

More funds like CFXRX →

CFXRX FAQ

What is the expense ratio of CFXRX?
CFXRX's expense ratio is 0.85%, which works out to about $85 a year for every $10,000 invested. The prospectus estimates total costs of $1,049 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is CFXRX a good investment?
It depends on your goals, but the data points to: 5-year return beat 89% of category peers; no front-end sales load. This is general information, not personalized advice.
What does CFXRX hold?
CFXRX's largest holdings are Hp Enterprise Co (1.5%), Texas Instruments Inc (1.5%), Cisco Systems Inc (1.4%), Oracle Corp (1.4%), Microchip Technology Inc (1.2%). It holds 170 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is CFXRX's 5-year return?
CFXRX returned +7.4% a year over the five years ending Dec 31, 2025, and +9.5% a year over ten years. Past performance does not guarantee future results.
Does CFXRX have a sales load?
No. CFXRX has no front-end sales charge.
Who manages CFXRX?
CFXRX is offered by Columbia Threadneedle through Columbia Funds Series Trust II.